Home Contact

New Jersey Stem Cell Research Symposium

Exploring academic and corporate stem cell research in New Jersey

Sponsored by:

Rutgers SCRC, The Human Genetics Institute of New Jersey, and Life Technologies

The Seventh Annual New Jersey Stem Cell Research Symposium

Co-sponsored by the Human Genetics Institute of New Jersey and Life Technologies, Inc.

The Seventh Annual New Jersey Stem Cell Research Symposium will be held on September 24, 2013 at the Bridgewater Marriott. Over 240 scientists are expected to attend the day-long event including presentations, posters, and exhibits.

The Sixth Annual New Jersey Stem Cell Research Symposium was a great success with over 250 scientists attending.

Abstract deadline: September 6, 2013. September 13, 2013

Registration deadline: September 13, 2013

 

Abstracts: The deadline has been extended to accomodate late-breaking results! Participants are invited to submit abstracts for poster presentations. The program committee will select several abstracts for oral presentation. You may begin to submit abstracts at any time, after registering. Begin by following the link to the registration page.

 

Program: The preliminary agenda is now posted, including leading speakers from key stem cell programs in New Jersey, Connecticut, New York, and Maryland.

Featured Speakers:

Scott Lipnick joined NYSCF in Spring 2012 as the Director of Scientific Programs. At NYSCF, he oversees partnerships with external scientific groups, intellectual property and technology transfer, and the external funding programs.  Prior to joining NYSCF, he most recently served as an American Association for the Advancement of Science (AAAS) Science and Technology Policy Fellow at the National Institutes of Health Center for Regenerative Medicine (NIH CRM). At NIH CRM, he managed the intramural stem cell pilot grant program, performed oversight of intellectual property issues related to stem cell projects to ensure there would be a clear path to the clinic, and facilitated seminars and working groups to develop teams to translate stem cell technologies. Prior to his time at the NIH, Scott obtained his PhD in Biomedical Physics from the University of California, Los Angeles, and a BS in Physics and Economics from Brandeis University.

Ren-He Xu is an associate professor of Department of Genetics and Developmental Biology, University of Connecticut Health Center, and the director of University of Connecticut-Wesleyan University Stem Cell Core.
He obtained M.D. from South China University and Ph.D. From University of Tokyo. He had postdoctoral training on developmental biology at the NIH and was a Senior Scientist of WiCell Research Institute studying human embryonic stem cells directed by Dr. James Thomson. He joined UConn Health Center in 2006.

Jennifer Moore is the Associate-Director of the National Institute of Mental Health’s (NIMH) Stem Cell Resource at Rutgers, the State University of New Jersey.  Dr. Moore received her bachelor’s of science degree from the University of North Carolina at Charlotte in Chemistry and her Ph.D. from the University of North Carolina at Chapel Hill in Biochemistry and Biophysics.  Her graduate research focused on the role of the cell cycle in the early development of sea urchins.  Dr. Moore then joined Dr. Christine Mummery’s lab at the Hubrecht Laboratory in Utrecht, the Netherlands, where she studied the role of protein signaling in the cardiac differentiation of human embryonic stem cells (hESC).  She continued her post-doctoral studies in the field of human embryonic stem cell derived cardiomyocytes at the University of California, Davis, focusing on the use of genetic strategies to drive chamber specific cardiomyocyte differentiation.  At the NIMH Stem Cell Resource, Dr. Moore oversees the generation of iPSC and their differentiation into neural derivatives for the study of psychiatric disorders. 

Gabsang Lee is an Assistant Professor in the Department of Neurology and the Institute of Cell Engineering at Johns Hopkins University in Baltimore. He is a recipient of the Druckenmiller Fellowship and is currently a Robertson Investigator of the New York Stem Cell Foundation. He received his Ph.D. and D.V.M. from Seoul National University in Seoul, Korea. He then completed postdoctoral training with Prof. Lorenz Studer at Sloan Kettering Institute. His lab is currently exploring fate determination of different neural crest subtypes, including nociceptive neurons, sympatho-adrenal lineages, Schwann cells and recently successfully convert human postnatal fibroblasts into induced neural crest fate, providing additional insights on peripheral nervous system disorders.